Status:
UNKNOWN
Comparing the Efficacy of Local Anesthetics in Mohs Surgery
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborating Sponsors:
Richard J. MacKay Endowment Fund
Benefactor Life Members' Research Grant
Conditions:
Lidocaine
Bupivacaine
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Mohs surgery is a very effective option in removing non-melanoma skin cancers, as the tissue being removed is analyzed the same day. If there are remnants of cancer cells in the tissue removed, the Mo...
Detailed Description
Mohs surgery is a very effective option in removing non-melanoma skin cancers, as the tissue being removed is analyzed the same day. If there are remnants of cancer cells in the tissue removed, the Mo...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Confirmed diagnosis of non-melanoma skin cancer
- Written informed consent
Exclusion
- Documented or reported history of adverse reaction to lidocaine or bupivacaine
- Active soft tissue infection at site of surgery
- Participants who require more than 3 stages of excision
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 14 2021
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT03871478
Start Date
October 1 2019
End Date
June 14 2021
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohs Surgery Clinic
Ottawa, Ontario, Canada, K1H 7W9